A rrhythmogenic cardiomyopathy (ACM; Mendelian Inheritance in Man number 107970) is the second most common cause of unexpected sudden death among young people and athletes. 1, 2 Its main clinical features comprise structural and functional abnormalities of the ventricles and ventricular arrhythmias. 2, 3 The subform predominantly involving the right ventricle (RV) (arrhythmogenic right ventricular cardiomyopathy) is the most common even though left and biventricular forms are also well documented. 4, 5 ACM's distinct histopathologic profile consists of the progressive replacement of the myocardium by fatty or fibro-fatty tissue, starting from the epicardium toward the endocardium and eventually becoming transmural. 6 The disease is familial in about half of the cases and typically shows an autosomal dominant inheritance, with reduced penetrance and variable expression. 7 A genetic cause can be established in ≈60% of the patients. 8 The majority of pathogenic variants in ACM have been identified in genes encoding the intercalated disk (ID) proteins JUP (plakoglobin), 9 DSP (desmoplakin), 10 PKP2 (plakophilin-2), 11 DSG2 (desmoglein-2), 12 DSC2 (desmocollin-2), 13 CTNNA3 (α-T-catenin), 14 and CDH2 (N-cadherin). 15, 16 A few other mutations have been found in non-ID genes encoding cardiac RYR2 (ryanodine receptor 2), 17 TGFβ3 (transforming growth factor β3), 18 TMEM43 (transmembrane protein 43) , 19 DES (desmin), 20 TTN (titin), 21 LMNA (lamin A/C), 22 PLN (phospholamban), 23 and SCN5A (sodium voltage-gated channel α subunit 5). 24 Here, we report the identification of likely pathogenic variants in the tight junction protein 1 (TJP1) gene in patients with ACM, thereby linking pathogenic variants in TJP1 with a human disease for the first time. TJP1 encodes for a scaffolding protein, called ZO-1 (zonula occludens-1), which interacts with various components of cardiac ID.
MATERIALS AND METHODS
Raw data, analytic methods, and study materials are available on request from the corresponding author for purposes of reproducing the results or replicating the procedure. The study protocol was approved by the ethics committee review board of the University of Padua (Padua, Italy) and of the Amsterdam University Medical Center (Amsterdam, The Netherlands). Methods are available as Data Supplement.
RESULTS

Genetic Screening
Proband II-4 of family A, negative for point mutations and copy number variations in the most frequently mutated ACM genes, was screened by whole-exome sequencing. After the removal of sequencing adapters and trimming of low-quality bases, ≈25 Gb of cleaned sequencing bases were obtained. A total of 99.99% of the sequencing reads was aligned to the human reference genome (hg19), with 63.17% effective reads from target regions being obtained after the removal of polymerase chain reaction duplications. The average sequencing depth was 216.57-fold, with 98.57% of target regions having at least a 10-fold coverage.
As a result, 21 711 single nucleotide polymorphisms and 644 InDels were identified. On excluding synonymous variants outside splicing regulatory sites and predicted benign missense variants, 52 novel or rare variants with a minor allele frequency ≤0.01% were filtered (Table I in the  Data Supplement) . TJP1 which encodes a multifunctional protein interacting with various components of the cardiac ID called ZO-1, resulted the first ranked gene by 2 different prioritization tools ( Figure 1A ; Table II in the Data Supplement).The p.(Y669C) missense variant was absent from all databases and was predicted to be damaging by 8 in silico tools ( Figure 1B ).This variant has a combined annotation dependent depletion C score of 25.5 ( Figure 1B) ; of note, a C score >20 indicates that it is among the top 1% of deleterious variants in the human genome. p.(Y669C) affects a highly conserved amino acid at the GUK (guanylate kinase)-like domain of ZO-1 ( Figure 1C ). Sanger sequencing confirmed the presence of this heterozygous variant in the proband and in 6 of 9 family members ( Figure 2) .
The presence of additional variants in exons with a coverage <15× of known ACM genes was excluded by Sanger sequencing in the proband's DNA.
Targeted genetic screening of TJP1 in 40 additional Italian patients with ACM identified the likely pathogenic variant c.793C>T p.(R265W) in the proband of family B. This variant is present in gnomAD database with a minor allele frequency of 0.001% (2 of 111 550 alleles) in European individuals. It is predicted to be damaging by 8 in silico tools, and its combined annotation dependent depletion C score is 33 ( Figure 1B ), indicating that it is among the top 0.1% of deleterious variants in the human genome. This variant affects a highly conserved amino acid localized just after the end (at position 261) of the second PDZ domain of ZO-1 ( Figure 1C) .
To exclude the presence of additional mutations in ACM genes or in other candidate genes, the proband's DNA was also analyzed by whole-exome sequencing. After removing low-quality reads, ≈18.2 Gb of cleaned sequencing bases were obtained; 99.98% of the sequencing reads was aligned to the human reference genome (hg19), with 62.93% effective reads from target regions being obtained after the removal of polymerase chain reaction duplications. The average sequencing depth was 162.26-fold, with 98.07% of target regions having at least a 10-fold coverage. As a result, 21 691 single nucleotide polymorphisms and 630 InDels were identified. Among them, 48 variants were filtered as described above (Table III in the Data Supplement). Once again, TJP1 resulted the first ranked gene by 2 different prioritization tools ( Figure 1A ; Table IV in the Data Supplement). The presence of additional variants was excluded in all exons of ACM genes with a coverage <15× by Sanger sequencing. In family B, the affected proband's sister (II-3) turned out to also have this variant (Figure 2 ).
In addition, whole-exome sequencing data have been analyzed from an independent cohort of 43 Dutch/German patients with a clinical diagnosis of ACM; among them, 11 fulfilled the formal criteria for its subform arrhythmogenic RV cardiomyopathy, whereas 32 had a diagnosis of nonischemic dilated cardiomyopathy with recurrent sustained ventricular tachycardia (VT). Two missense pathogenic variants in TJP1 (c. 986C>T, p.(S329L) and c.1079A>T, p.(D360V)) have been identified in 2 probands. As before, TJP1 gene was ranked first by Endeavour in both patients ( Figure 1A ; Tables VI and VII in the Data Supplement). The p.(S329L) variant, identified in a proband negative for mutations in ACM genes, is present in gnomAD database with a minor allele frequency of 0.006% (16 of 269 882 alleles) and is predicted to be damaging by 6 in silico tools, and its combined annotation dependent depletion C score is 30 ( Figure 1B) . The p.(D360V) variant, identified in a proband carrying also the p.(I156N) pathogenic variant in DSP, is absent from all databases, is predicted to be damaging by 5 in silico tools, and its combined annotation dependent depletion C score is 28.5 ( Figure 1B ). In the absence of additional affected family members, we cannot define the pathogenic role of TJP1 and DSP variants.
Both TJP1 variants affect highly conserved amino acids localized between PDZ2 and PDZ3 domains. Sanger sequencing confirmed the presence of these heterozygous variants in both probands.
Interestingly, TJP1 showed a probability of being a loss-of-function intolerant (pLI) gene of 1. A gene with a pLI value ≥0.9 is considered extremely loss-of-function intolerant. In gnomAD database, 1160 TJP1 variants with a minor allele frequency ≤0.01% were reported in 1415 of 1 38 632 (1%) subjects. Among these variants, only 228 were predicted to have a probably damaging effect and were identified in 272 of 1 38 632 (0.19%) subjects. However, we identified 4 likely pathogenic variants in 4 
Clinical Data
Family A was evaluated after the sudden death of a 36-yearold man (II-2); a few months before, he presented with a syncopal episode during effort. ECG showed negative T waves in V1 to V3, whereas on a 2-dimensional echocardiogram the RV was dilated (RV outflow tract from the parasternal long-axis view=42 mm; RV outflow tract from the parasternal short-axis view=41 mm) with a reduced systolic function (fractional area change: 30%) and presence of kinetic abnormalities (Table; Table VIII in the Data Supplement). Before a cardiac magnetic resonance imaging was made, he died during effort. Autopsy was performed at another hospital leading to a diagnosis of an unspecified cardiomyopathy. Histological slides, which were later reviewed at our center, showed fibro-fatty replacement in the free wall of both ventricles together with myocardial atrophy, features in keeping with ACM ( Figure 3 ). The 35-year-old brother (II-4) was then evaluated in our outpatient clinic and diagnosed with ACM (Table) . ECG showed intraventricular conduction delay, negative T waves in V1 to V5, and low QRS voltages ( Figure 4A ). At 24-hour Holter ECG, frequent premature ventricular contractions with left bundle branch block morphology were detected. Magnetic resonance imaging showed RV dilatation with regional kinetic abnormalities; the left ventricle (LV) was also dilated with mild diffuse hypokinesia. Moreover, late gadolinium enhancement as mid-mural striae was detectable in the inferior-lateral wall of LV ( Figure 4B ). One additional brother (II-9) fulfilled the ACM diagnostic criteria. The proband's mother (I-1) was asymptomatic and showed negative T waves in V1 to V2, whereas the 2-dimensional echo was normal. Finally, subjects III-1, III-2, and III-5, who were children at the time of clinical examination, and the remaining proband's brother (subject II-6) did not show clinical and instrumental signs of the disease, in line with ACM incomplete penetrance (Table) .
The proband of family B was a woman diagnosed with ACM at the age of 51 years. She underwent cardiac evaluation for palpitations. ECG showed negative T waves in V1 to V3 and frequent premature ventricular contractions at 24-hour Holter ECG. Two-dimensional echo revealed a moderated dilatation and dysfunction of the RV (Table) . During the familial screening, the 65-year-old sister was also diagnosed with ACM, showing negative T waves in V1 to V2 and frequent premature ventricular contractions with left bundle branch block morphology. Her 2-dimensional echo showed mild RV dilation with normal function (Table) .
Proband C carrying the p.(S329L) variant was a man with dilated cardiomyopathy at the age of 55 years. He underwent cardiac evaluation because of progressive dyspnea. His LV ejection fraction was estimated at 33%, with a LV end-diastolic diameter=76 mm. RV function was considered normal, with just moderately depressed contractility. The family history was negative. ECG showed no repolarization abnormalities. He was further known with persistent atrial fibrillation, renal dysfunction, diabetes mellitus, and hypertension. At the age of 61 years, he had an electrical storm that was treated by medication. At the age of 62 years, he was referred to the hospital for VT ablation because of recurrent VTs with implantable cardioverter defibrillator shocks. Electroanatomic mapping revealed an arrhythmogenic substrate in the posterior-basal LV epicardium and in the anterior-basal septal endocardium. He had VT recurrence after 1 year. Six months later, he received an LV assist device because of progression of heart failure.
Proband D, carrying the p.(D360V) variant, was a man with dilated cardiomyopathy diagnosed at the age of 66 years. He underwent cardiac evaluation because of syncope and documentation of fast VTs with right bundle branch block morphology. LV ejection fraction was estimated at 40% (LV end-diatolic diameter=67 mm). RV function was considered normal. The family history was negative. ECG showed no repolarization abnormalities. He was further known with diabetes mellitus and hypertension. At the age of 73 years, he had an electrical storm and was referred to the hospital for VT ablation. Endocardial electroanatomic mapping revealed an arrhythmogenic substrate in the inferior-posterior basal LV with a septal extension. At the 2-year follow-up, he had no VT recurrence.
In Silico Prediction of the Effects of ZO-1 Likely Pathogenic Variants
ZO-1 is a multidomain protein, presenting 3 consecutive PDZ (PDZ1-3) domains, an SH3 domain, a GUK domain, and a ZU5 domain, as reported in the PFAM database. Our alignment of 43 orthologous sequences showed that amino acid R265 and the 9 residues immediately downstream are fully conserved between species. We then checked if the structural characteristics of the ZO-1 fragment Figure I in the Data Supplement), 2 of them suggest that this mutation may impair ZO-1 interaction with MAP (mitogen-activated protein) kinases. However, the prediction confidence is low, thus not allowing further speculation about its pathogenic effect.
The p.(Y669C) likely pathogenic variant is localized within the GUK domain. This enzymatically inactive domain is connected to the PDZ3 domain through an SH3 module acting as a linker. 25 The variant falls at the contact region between strands β2/β3, which are members of a large 5 β-sheet structure which forms the GUK hydrophobic core. We performed a 40 ns full atom molecular dynamics simulation to investigate the structural impact of the p.(Y669C) variant. Analysis of the trajectories showed the wild-type protein to be relatively more stable than the mutant. In particular, root mean square deviation analysis showed the wild-type protein fluctuating ≈0.3 nm ( Figure 5B ). We also observed a short peak of 0.5 nm between 12 and 18 ns of simulation. Frames inspection revealed that the increase was because of the movement of a single loop within residues 586 to 631. In the same simulation conditions, the mutant protein showed a root mean square deviation peak of 0.5 nm, reached after only few ns, while the root mean square deviation value remains over 0.4 nm for the entire simulation. Structural comparison between the last frames calculated for each run showed that p.(Y669C) could induce a visible structural rearrangement of the GUK domain. When superimposed, the proteins showed a similar organization for the PDZ3 domain while the GUK domain resulted to adopt a more opened conformation in the mutated protein ( Figure 5B ). Hence, we propose that increased mobility of the GUK domain is compatible with a local unfolding induced by p.(Y669C). A network of interacting residues generated with RING ≈10 Å from position 669 showed that several hydrophobic interactions were lost during the simulation of the mutant protein. In particular, p.(Y669C) broke the van der Waals interactions between Y669 and L66, I789, promoting a clear structural rearrangement.
The crystal structure of the ZO-1 N-terminal domain, in which p.(R265W), p.(S329L), and p.(D360L) variants are located, is not available. Therefore, a molecular dynamics simulation could not be performed.
DISCUSSION
Here, we provide the first description of likely pathogenic TJP1 variants identified in patients with ACM; no previous association of TJP1 variants to inherited human diseases has been reported. The 4 probands fulfill the current diagnostic criteria for arrhythmogenic RV cardiomyopathy or had dilated cardiomyopathy with recurrent sustained VTs and 3 of them resulted negative for pathogenic/likely pathogenic variants in all known ACM genes and for copy number variations in the most frequently mutated genes. Moreover, no additional pathogenic variants have been identified in obvious ACM candidate genes by whole-exome sequencing analyses. Mutation screening performed in all available family members revealed that all affected subjects were mutation carriers.
TJP1 gene encodes the multifunctional protein ZO-1, which comprises 4 different domains, PDZ, SH3, GUK, and ZU5, and interacts with different proteins of the ID.
This latter is a specialized organelle in which mechanical and electrical junctions are interlinked via proteinprotein interactions. 26 The ID components were initially described as independent; however, it has been demonstrated that in cardiac tissue of higher order mammalian species, they actively interact and form multiprotein complexes called area composita (constituted by proteins of desmosomes and adherens junctions) and connexome (constituted by proteins of desmosomes, gap junctions [GJs], and sodium channel complex). 26 In cardiomyocytes, ZO-1 is essential for a normal organization of both GJs and area composita, interacting with Cx43 (connexin43) and CDH2, respectively. 27, 28 It has been reported that ZO-1 regulates the number, size, and distribution of GJs, binding Cx43 molecules present at the perinexus, an area adjacent to the functional GJs. 29, 30 Free connexons in the perinexus are unable to associate with connexons of neighboring cells as long as ZO-1 is bound. 26 In ventricles from patients with congestive heart failure, showing GJs remodeling, ZO-1 protein levels were significantly increased, whereas Cx43 expression was downregulated; the proportion of Cx43 interacting with ZO-1 was significantly enhanced, thus suggesting that ZO-1 prevents the formation of functional GJs. 27 Interestingly, Palatinus et al 28 reported that the regulation of functional GJ localization at cell-cell interactions between cardiomyocytes does not depend on the ZO-1-Cx43 interaction only but also on the level of ZO-1 association with the CDH2 in the area composita. ZO-1 forms a molecular link between GJs and area composita, interacting with Cx43 via the second PDZ domain 31 and connecting cadherin to the actin filaments through the interaction with α-catenin.
32,33
Tjp1 knockout mice showed embryonic lethal phenotype associated with massive apoptosis in the notochord, neural tube area, and allantois, as well as defective yolk sac angiogenesis, hence indicating an essential role of Tjp1 in early embryonic development. Heterozygous Tjp1 +/-mice showed no obvious pheno- types, with fertility and growth rates comparable to those of wild-type mice. 34 Moreover, established ZO-1 knockout Madin-Darby canine kidney cells showed remarkable changes comparable in myosin organization at cell-cell contacts and an altered localization of tight junction proteins. These changes were reversed by trace ZO-1 expression although an excessive ZO-1 level induced an altered shape of cell-cell junctions. 35 The 4 likely pathogenic missense ZO-1 variants reported in the present study affect highly conserved amino acid residues and are predicted as deleterious by at least 5 prediction tools, hence suggesting a functional role for these residues. The p.(R265W) pathogenic variant is located in a conserved extension of the PDZ2 domain. Because of its localization, formally outside the PDZ2, this variant could be considered not relevant for correct PDZ domain folding. Previous structural investigation conducted through nuclear magnetic resonance spectroscopy has indeed shown that this residue falls in an intrinsically disordered region. 36 However, it has been described that disordered regions may undergo specific phase transitions depending on their amino acid composition and binding partners. 37 Our predictions of the local structure content of both wild type and mutant proteins suggest that the intrinsically disordered fragment 265 
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275 forms an additional PDZ2 β-strand, whereas p.(R265W) variant induces its destabilization. Several PDZ domains are known to present extra regulative regions that extend ) with impaired systolic function and focal bulging on the lateral wall (white arrow on diastolic frame in image 1 and on systolic frame in image 2). On T1-inversion recovery, post-contrast sequence late gadolinium enhancement as mid-mural striae was detectable in the inferior-lateral wall of left ventricle on 3-chamber long-axis view (3), confirmed in the orthogonal short-axis view (4; empty arrows), suggesting a typical finding of arrhythmogenic biventricular cardiomyopathy.
over the C-terminus boundary and frequently assume a regulative role, for example, improving domain stability and modulating the ligand-binding specificity. 38, 39 As a relevant example, PDZ3 of ZO-1 presents itself an accessory C-terminal tail, which acts as both a stabilizer of PDZ3/SH3 domain-domain interaction and a ligandbinding site. 40 Because of the high conservation and the results of our in silico investigation, we hypothesize that the p.(R265W) variant could impair the regulative function of the PDZ2-C-terminus region.
The other 2 likely pathogenic variants p.(S329L) and p.(D360V) localize in a linker region connecting PDZ2 and PDZ3 and overlap different putative linear motifs involved in protein-protein interaction. Large-scale studies of human phosphor-proteome showed that the S329 is a phosphorylation site thought to be implicated in embryotic differentiation and cell mitosis. 41, 42 One may speculate that p.(S329L) impairs ZO-1 association with an unknown protein containing a WW domain, a modular protein domain that binds to phosphoserine containing motifs. 43 However, the pathogenic effect of these 2 variants may be mostly related to a local destabilization of the disordered linker, rather than to a specific functional impairment.
The p.(Y669C) variant falls inside the GUK domain, for which a crystal structure is available. 25 Molecular dynamics simulation revealed that the mutant protein is less stable than the wild type, showing a remarkable loss of hydrophobic interactions around the mutated area and a more open conformation of the GUK domain. Lye et al 25 presented a structural comparative study between ZO-1 and ZO-3, demonstrating that the main difference between the 2 proteins is a more open conformation of the GUK domain in ZO-3. This variation in conformation between ZO-1 and ZO-3 might explain the inability of ZO-3 to localize to tight junctions in the absence of either ZO-1 or ZO-2. Our findings suggest that the local unfolding induced by the p.(Y669C) variant promotes a structural rearrangement which forces the ZO-1 GUK domain to assume a conformation closer to ZO-3.
Taking into account the localization of the ZO-1 likely pathogenic variants and the role of ZO-1 in the cardiac ID, we hypothesize that the mutated proteins alter their binding with the main ZO-1-interacting proteins, such as Cx43 or CDH2, thus causing a possible impairment of the area composita and the connexome. In this perspective, the identification of ZO-1 pathogenic variants in patients with ACM underlines the potential direct involvement in ACM pathogenesis not only of the mechanical components of the ID (area composita and desmosome) but also of the electrical ones (GJ).
In summary, multiple lines of evidence, such as cardiac expression of TJP1 and function of the encoded protein ZO-1, cosegregation of the variants with the phenotype in two families, high conservation of involved amino acids, and the in silico predictions of pathogenicity and of the effects of the variants, suggest a causal relationship between TJP1 pathogenic variants and ACM. Therefore, because the prevalence of TJP1 variants in our cohort of patients with ACM is just <5%, we propose a systematic screening for this gene to determine the prevalence of variants in different cohorts of patients with ACM in a research setting. Further studies will be needed to better understand the pathogenic effects of these variants, the behavior of the mutant ZO-1 proteins in vivo, and the molecular mechanism leading to the ACM phenotype.
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